Analyst David Palmer upgraded the casual dining restaurant company to outperform from in line.
Related Posts
FDA approves Vertex’s non-opioid painkiller, first new kind of pain medicine in decades
The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive potential of opioids.
After last year’s $162-billion stock wipeout, Samsung’s 2025 hinges on Nvidia
Samsung is waiting for Nvidia to approve use of its high-bandwidth memory, which analysts say is key to improving the tech giant’s profitability.
Here’s the deflation breakdown for October 2024 — in one chart
There are still some pockets of deflation in the U.S. economy, though the dynamic has become more muted as supply chains normalize, economists said.